Primary sclerosing cholangitis (PSC)
Conditions
Interventions
None listed
Sponsors
Ipsen Pharma
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Countries
Netherlands
Outcome results
None listed